Type 2 Diabetes Clinical Trial
Official title:
E-coaching for Patients With Abdominal Obesity and Type 2 Diabetes : the A.N.O.D.E. Study
Abdominal obesity and its metabolic consequences, particularly type 2 diabetes, require personalized nutritional monitoring. Today, it is not always possible to provide patients with appropriate care to both, the diet plan, physical activity, stress and sleep management. Emerging data have shown the effectiveness of remote support (e- coaching), in order to increase the level of physical activity and reducing calorie intake which causes weight loss similar to that obtained during a face to face consultation. Compared to a food survey conducted by a dietician, the dietary survey MXS computer software showed similar results on the collection of nutritional data. Furthermore, users preferred this method of remote collection compared to direct interview. The investigators recently developed a tool for e-coaching combining this computerized dietary survey and education and support modules on diet and physical activity (MXS- health program) for the patients. The aim of the investigators' study is to compare efficacy of this new software vs usual care.
Description of nutritional intervention in both groups:
Both groups make the same visits, answer the same questionnaire and dietary surveys. Only
nutrition and physical activity recommendations differ depending on whether the patient is
randomized to the intervention group or the control group.
- Intervention group: e-coaching: patients benefit from the MXS-health support program
including self-monitoring modules, generation of adequate nutritional recipes, education
and support for physical activity. They receive an access code and personal password
during the randomization visit
- Control group: usual recommendations: Control subjects will simply follow the usual
nutritional recommendations provided during the monitoring of their diabetes. They will
be informed of the possibility to benefit from the e-coaching program at the end of the
study.
Research hypotheses
Assumptions related to this research are :
- The MXS -health e-coaching program improves adherence to nutritional recommendations in
patients with abdominal obesity and type 2 diabetes.
- Adhesion to the e-coaching program can be predicted by simple criteria based on the
characteristics of the patient and a self-administered questionnaire including
socio-professional characteristics and the level of food impulsivity.
Main objective To show that within four months, the e-coaching improves eating habits. The
primary endpoint is the comparison of the changes between the first (D-20 D-2) and the second
survey (D100 to D118) of dietary score (International Diet Quality Index) between both groups
(e-coaching versus usual nutritional recommendations).
Secondary objectives
- To show that the e-coaching provides in four months, an increase in both duration and
abilities for physical activity,
- To identify predictors of the effectiveness and adherence to the e-coaching program
which take into account the average number of weekly connections and the percentage of
tasks required by the software (watch a video, fill a questionnaire ...) performed by
the included patients,
- To evaluate the effectiveness of e-coaching on glycaemic control (HbA1c) and the
cardiometabolic risk profile (lipid parameters, blood pressure, waist circumference,
weight, hs-CRP, transaminases, adiponectin),
- To evaluate the effectiveness of e-coaching on physical fitness (VO2 max calculated
during a graded exercise test) and the amount of physical activity performed (IPAQ
questionnaires).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |